Mein Warenkorb

C1q R1

C1q R1 Molekülinformation

Englischer NameComplement component C1q receptorAnzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel0Target-AliasC1q/MBL/SPA receptor,C1qR,C1qRp,C1qR(p),CDw93,Complement component 1 q subcomponent receptor 1,Matrix-remodeling-associated protein 4
Höchste Forschungs- und EntwicklungsphasePreclinical
Englischer NameComplement component C1q receptor
Target-AliasC1q/MBL/SPA receptor,C1qR,C1qRp,C1qR(p),CDw93,Complement component 1 q subcomponent receptor 1,Matrix-remodeling-associated protein 4
Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel0
Höchste Forschungs- und EntwicklungsphasePreclinical

C1q R1 Produktliste

  • Attribut

    Protein (2)

  • Produktbibliothek

    Online (2)

  • Spezies

    Human (2)

  • Etikett

    His Tag (1)His Tag & Avi Tag (1)

  • Marker

    Unconjugated (1)Biotin-labeled (1)

ProduktnummerSpeziesExpressionssystemProduktbeschreibungProteinstrukturReinheitEigenschaftenVorbestellen/Bestellen
Human
HEK293
Human C1q R1 / CD93 Protein, His Tag (MALS verified)
In den Warenkorb legen
Human
HEK293
Biotinylated Human C1q R1 / CD93 Protein, His,Avitag™
In den Warenkorb legen
Gesamtmenge2
  • 1

C1q R1 Molekülhintergrund

CD antigen CD93 is also known as Complement component C1q receptor (C1QR1). which belongs to the Group XIV C-Type lectin family, a group containing two other members, endosialin (CD248) and thrombomodulin. CD93 contains one C-type lectin domain and five EGF-like domains. CD93 is highly expressed in endothelial cells, platelets, cells of myeloid origin, such as monocytes and neutrophils. CD93 is receptor for C1q, mannose-binding lectin (MBL2) and pulmonary surfactant protein A (SPA). CD93 may mediate the enhancement of phagocytosis in monocytes and macrophages upon interaction with soluble defense collagens and may play a role in intercellular adhesion.

C1q R1 Molekülalias

CD93,CDw93,C1QR1,MXRA4,C1qR,C1qR(P),C1qRP,ECSM3
  • Molekülinformation
  • Produktliste
Kontaktieren Sie uns